Over the past decade, there has been an increasing use of supplements and alternative medicines (CAM). For patients with prostate cancer, CAM is used most often by those who have been diagnosed and treated, and patients with progressive disease are more likely to use CAM than patients with stable disease Pomegranate juice is an antioxidant that has attracted increasing attention in recent years. 1, pomegranate juice which contains a large number of polyphenol flavonoids, has antioxidant and anti-atherosclerotic effects. Epidemiological studies have shown that the intake of fruits and vegetables rich in phenolic compounds is associated with lower cancer mortality. Pomegranate juice, an antioxidant-rich product, has been studied in laboratories for its potential to prevent prostate cancer. Because industrial processing extracts certain tannins from the peel, commercial pomegranate juice is rich in flavanones, so consumption of pomegranate juice, especially processed including the peel, is beneficial. 2, tea Tea is second only to water in the world’s most widely consumed beverage. Green tea, oolong tea and black tea are all made from the leaves of the tea tree, because the process is different resulting in their chemical composition and flavor is very different. Green tea contains a number of polyphenolic compounds, including several polyphenols and the gallocatechin pentaerythate (EGCG), and is safe to drink. A study of 49 patients with solid tumors found that drinking 3.5 to 4 cups of green tea at a time, three times a day, was easily tolerated and safe to consume for at least six months. Epidemiological studies have found that men who regularly consume green tea have a lower incidence of prostate cancer. Another study found that Asian men who drink large doses of green tea have a lower incidence of prostate cancer than Western men. The function of legumes and the preventive effect of phytoestrogens contained in them on prostate cancer has been a hot topic of research. Most studies have focused on two classes of isoflavones, specifically 5,7,45-trihydroxyisoflavones and isoflavone glycosides. Epidemiological studies have found a low incidence of prostate cancer in populations with diets rich in soy products, with lower rates of prostate cancer reported in Chinese and Japanese men than in American-born men, and rates of prostate cancer in Asian immigrants in the United States consistent with those in Americans. Dietary intake of soy products may be responsible for these differences, as surveys have found that the average Asian diet contains 10 times more soy products than the standard American diet, and that Asian isoflavone intake is 50 mg/d compared to only 2 to 3 mg/d for Americans. in a survey of the dietary habits of 12,395 explorers in the United States, it was found that men who consumed soy milk more than once a day had a lower prostate cancer The incidence of prostate cancer was 70% lower than that of non-drinkers.